Food - Can It Really Prevent Cancer?October 21, 2003Food is a major and underused anticancer weapon, according to the All-Party Parliamentary Group on Cancer. In collaboration with the Institute of Food Research, the Group is calling for diet to be better deployed in reducing cancer risk in the UK. "With dietary interventions, we have the potential to prevent around a third of all cancers", according to Dr Ian Gibson MP, Chair of the All-Party Parliamentary Group on Cancer. "In the long term, we could also save some of the £2.4-3.5 billion annual cost to the NHS of cancer", he adds. Seventy percent of cancer treatment money is spent during the terminal stages, while less than ten percent of total cancer research funding is focused on prevention. This is at odds with the overwhelming epidemiological evidence that many cancers are preventable. "The biological mechanisms of cancer prevention through diet can be discovered and exploited in the same way as new curative drugs", says Professor Ian Johnson of the Institute of Food Research. "Scientific advances should be as vigorously applied to prevention strategies as they are to drug development", he says. This needs to be accompanied by an investment in public awareness of the links between food and cancer prevention. Research has shown that they are often poorly understood. For example, an IFR study of beliefs amongst low-income women found that foods were not generally linked to cancer prevention. What connections were made between food and cancer revolved around beliefs that food processing might cause cancer. However, "the strongest association between diet and cancer in the western world is the protective effect of a high intake of fruit and vegetables", says Professor Johnson. "In the next Cancer Plan, let's try to get it right for the sake of the economy, the long term future of the NHS, and the health of the next generation", says Dr Ian Gibson MP. | |||||||||||||||||||||
|
Related Cancer Current Events and Cancer News Articles Metabolic reactions: Less is more in single-celled organisms A Northwestern University study has found a surprising similarity among four quite different organisms. The simplest organism, a bacterium called H. pylori, uses the same number of biochemical reactions (around 300) as yeast, the largest, most complex organism of the group, when optimizing growth. Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene. International study supports new standard of treatment for women with advanced ovarian cancer Results of a phase III, international randomized clinical trial demonstrate a new standard of care for treating advanced ovarian cancer that significantly reduces side-effects and post-operative deaths compared to the previously established treatment course. Researchers identify cell group key to Lyme disease arthritis A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease. Researchers Discover New Enzyme in Cancer Growth While studying the mechanics of blood clots, researchers at the University of Oklahoma Health Sciences Center discovered a new enzyme that not only affects the blood, but seems to play a primary role in how cancer tumors expand and spread throughout the body. Angled gantry technique reduced breast radiation exposure by 50 percent A novel angled gantry approach to coronary CT angiography reduced radiation exposure to the breast by more than 50%, according to Thomas Jefferson University researchers. HER2 levels may aid in treatment selection for metastatic breast cancer Findings published in the December 1, 2008, issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, show lapatinib benefits women with HER2-positive breast cancer, while women with HER2-negative breast cancer or those who express EGRF alone derive no incremental benefit. Drop in cancer deaths tied primarily to gains in behavior and screening Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University. Plants display 'molecular amnesia' Plant researchers from McGill University and the University of California, Berkeley, have announced a major breakthrough in a developmental process called epigenetics. They have demonstrated for the first time the reversal of what is called epigenetic silencing in plants. New breast imaging technology targets hard-to-detect cancers Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||